Source: Nutrition Insight

Prolacta: Homogenized human milk-based products may be unsafe for premature infants, flags Prolacta Bioscience

28 Mar 2022 --- Human milk-based nutritional products should not be homogenized until the process's safety and efficacy has been established, according to a paper backed by Prolacta Bioscience. It notes that this process disrupts the milk fat globule, which may lead to premature digestion of bioactive components - with unknown implications for infant health.

Read full article »
Est. Annual Revenue
$500M-1.0B
Agree?
Est. Employees
250-500
Agree?
Scott A. Elster's photo - CEO of Prolacta

CEO

Scott A. Elster

CEO Approval Rating

50/100

Read more